MacroGenics Reconciled Depreciation from 2010 to 2024

MGNX Stock  USD 3.21  0.07  2.13%   
MacroGenics Reconciled Depreciation yearly trend continues to be fairly stable with very little volatility. Reconciled Depreciation is likely to outpace its year average in 2024. During the period from 2010 to 2024, MacroGenics Reconciled Depreciation regression line of annual values had r-squared of  0.69 and arithmetic mean of  8,856,150. View All Fundamentals
 
Reconciled Depreciation  
First Reported
2012-09-30
Previous Quarter
1.8 M
Current Value
1.8 M
Quarterly Volatility
1.5 M
 
Yuan Drop
 
Covid
Check MacroGenics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among MacroGenics' main balance sheet or income statement drivers, such as Depreciation And Amortization of 7.3 M, Interest Expense of 1.5 M or Selling General Administrative of 37 M, as well as many indicators such as Price To Sales Ratio of 9.98, Dividend Yield of 0.0 or PTB Ratio of 4.1. MacroGenics financial statements analysis is a perfect complement when working with MacroGenics Valuation or Volatility modules.
  
Check out the analysis of MacroGenics Correlation against competitors.
For more information on how to buy MacroGenics Stock please use our How to Invest in MacroGenics guide.

Latest MacroGenics' Reconciled Depreciation Growth Pattern

Below is the plot of the Reconciled Depreciation of MacroGenics over the last few years. It is MacroGenics' Reconciled Depreciation historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in MacroGenics' overall financial position and show how it may be relating to other accounts over time.
Reconciled Depreciation10 Years Trend
Slightly volatile
   Reconciled Depreciation   
       Timeline  

MacroGenics Reconciled Depreciation Regression Statistics

Arithmetic Mean8,856,150
Geometric Mean8,657,689
Coefficient Of Variation22.56
Mean Deviation1,813,646
Median7,228,000
Standard Deviation1,998,314
Sample Variance4T
Range4.7M
R-Value0.83
Mean Square Error1.3T
R-Squared0.69
Significance0.0001
Slope370,956
Total Sum of Squares55.9T

MacroGenics Reconciled Depreciation History

202411.2 M
20239.6 M
202211.9 M
202111.3 M
202012 M
201910.8 M
20188.3 M

About MacroGenics Financial Statements

MacroGenics investors use historical fundamental indicators, such as MacroGenics' Reconciled Depreciation, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in MacroGenics. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Reconciled Depreciation9.6 M11.2 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for MacroGenics Stock Analysis

When running MacroGenics' price analysis, check to measure MacroGenics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MacroGenics is operating at the current time. Most of MacroGenics' value examination focuses on studying past and present price action to predict the probability of MacroGenics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MacroGenics' price. Additionally, you may evaluate how the addition of MacroGenics to your portfolios can decrease your overall portfolio volatility.